We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dashboard Provides "Real-Time" Views of Pathology Lab Data

By LabMedica International staff writers
Posted on 22 Jul 2015
A new software addition to an anatomic pathology platform provides lab managers a quick and reliable, at-a-glance view of operational data, enabling to better monitor progress, anticipate bottlenecks, and avoid potential problems.

"Having the ability to monitor operational efficiency in real-time is crucial to a lab's success in today's time-pressed anatomic pathology environment," said Rick Callahan of NovoPath, Inc. More...
(Princeton, NJ, USA), "Typically, labs deal with problems after they negatively impact efficiency. With the NovoPath Dashboard, the lab manager can proactively monitor the pulse of the lab and make needed adjustments to eliminate bottlenecks and maximize efficiency." It presents critical statistical information in an easy-to-read graph or chart format for visual overview.

NovoPath is an anatomic pathology laboratory information management software platform that acts as a data warehouse for pathology cases and offers solutions for reporting, image acquisition, label printing, electronic signoff, synoptic reporting, voice dictation, billing, outreach, and more. It is designed for use at independent pathology practices and for easy integration with an existing Hospital Management System (HMS). It helps streamline workflows in a variety of settings, from general hospital to specialized reference labs, and supports adaptation to changing lab regulations. The platform is scaled to fit lab size, from multi-site, multi-facility labs examining thousands of cases per day to single-site labs.

"NovoPath is designed based on a deep understanding of anatomic pathology workflow and offers a broad range of flexible features," said Mr. Callahan, adding that deployment of such modules will help a lab succeed in a changing environment.

Related Links:

NovoPath



New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.